Alimentary Pharmacology & Therapeutics

Review article: the treatment of hepatitis C virus recurrence after liver transplantation
pp. 127-140(14)
Authors: ARJAL, R. R.; BURTON JR, J. R.; VILLAMIL, F.; ROSEN, H. R.

Review article: the prothrombin time test as a measure of bleeding risk and prognosis in liver disease
pp. 141-148(8)
Authors: TRIPODI, A.; CALDWELL, S. H.; HOFFMAN, M.; TROTTER, J. F.; SANYAL, A. J.

Review article: the pathophysiology of gastro-oesophageal reflux disease
pp. 149-160(12)
Author: BOECKXSTAENS, G. E. E.

Review article: nutrition, obesity and colorectal cancer
pp. 161-181(21)
Authors: JOHNSON, I. T.; LUND, E. K.

Systematic review: the prevalence of suicidal behaviour in patients with chronic abdominal pain and irritable bowel syndrome
pp. 183-193(11)
Authors: SPIEGEL, B.; SCHOENFELD, P.; NALIBOFF, B.

Systematic review: maintenance treatment of gastro-oesophageal reflux disease with proton pump inhibitors taken `on-demand'
pp. 195-204(10)
Authors: PACE, F.; TONINI, M.; PALLOTTA, S.; MOLTENI, P.; PORRO, G. B.

MMX Multi Matrix System^® mesalazine for the induction of remission in patients with mild-to-moderate ulcerative colitis: a combined analysis of two randomized, double-blind, placebo-controlled trials
pp. 205-215(11)
Authors: SANDBORN, W. J.; KAMM, M. A.; LICHTENSTEIN, G. R.; LYNE, A.; BUTLER, T.; JOSEPH, R. E.

Adherence to thiopurine treatment in out-patients with Crohn's disease
pp. 217-225(9)
Authors: BOKEMEYER, B.; TEML, A.; ROGGEL, C.; HARTMANN, P.; FISCHER, C.; SCHAEFFELER, E.; SCHWAB, M.

The burden of constipation on quality of life: results of a multinational survey
pp. 227-236(10)
Authors: WALD, A.; SCARPIGNATO, C.; KAMM, M. A; MUELLER-LISSNER, S.; HELFRICH, I.; SCHUIJT, C.; BUBECK, J.; LIMONI, C.; PETRINI, O.

Costs of health care for irritable bowel syndrome, chronic constipation, functional diarrhoea and functional abdominal pain
pp. 237-248(12)
Authors: NYROP, K. A.; PALSSON, O. S.; LEVY, R. L.; KORFF, M. VON; FELD, A. D.; TURNER, M. J.; WHITEHEAD, W. E.

Oral pantoprazole in the form of granules or tablets are pharmacodynamically equivalent in suppressing acid output in patients with gastro-oesophageal reflux disease and a history of erosive oesophagitis
pp. 249-256(8)
Authors: HOGAN, D.; PRATHA, V.; RIFF, D.; DUCKER, S.; SCHWARTZ, H.; SOFFER, E.; WANG, W.; RATH, N.; COMER, G. M.

Generation of dyspeptic symptoms by direct acid infusion into the stomach of healthy Japanese subjects
pp. 257-264(8)
Authors: MIWA, H.; NAKAJIMA, K.; YAMAGUCHI, K.; FUJIMOTO, K.; VELDHUYZEN VAN ZANTEN, S. J. O.; KINOSHITA, Y.; ADACHI, K.; KUSUNOKI, H.; HARUMA, K.

Adherence to gastroprotection and the risk of NSAID-related upper gastrointestinal ulcers and haemorrhage
pp. 265-275(11)
Authors: VAN SOEST, E. M.; STURKENBOOM, M. C. J. M.; DIELEMAN, J. P.; VERHAMME, K. M. C.; SIERSEMA, P. D.; KUIPERS, E. J.

Patients with sporadic duodenal adenoma are a high-risk group for advanced colorectal neoplasia: results of a case-control study
pp. 277-282(6)
Authors: PEQUIN, P.; MANFREDI, S.; QUENTIN, V.; HERESBACH, D.; BOYER, J.; SIPROUDHIS, L.; BRETAGNE, J.-F.

A randomized trial to determine the change in alanine aminotransferase during 10 days of paracetamol (acetaminophen) administration in subjects who consume moderate amounts of alcohol
pp. 283-290(8)
Authors: HEARD, K.; GREEN, J. L.; BAILEY, J. E.; BOGDAN, G. M.; DART, R. C.

Ribavirin with either standard or pegylated interferon to treat recurrent hepatitis C after liver transplantation
pp. 291-303(13)
Authors: CICINNATI, V. R.; IACOB, S.; KLEIN, C. G.; BABA, H. A.; SOTIROPOULOS, G. C.; HILGARD, P.; ERIM, Y.; BROELSCH, C. E.; GERKEN, G.; BECKEBAUM, S.

¹³C-methacetin breath test as a quantitative liver function test in patients with chronic hepatitis C infection: continuous automatic molecular correlation spectroscopy compared to isotopic ratio mass spectrometry
pp. 305-311(7)
Authors: GOETZE, O.; SELZNER, N.; FRUEHAUF, H.; FRIED, M.; GERLACH, T.; MULLHAUPT, B.